Torrent Pharma share price has zoomed 3% and is presently trading at Rs 3,414.5.
Meanwhile, the BSE HEALTHCARE index is at 42,793.0 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are LAURUS LABS (up 6.2%) and MAX HEALTHCARE INSTITUTE (up 1.9%).
GSK Pharma (down 3.7%) and CAPLIN POINT (down 3.5%) are among the top losers today.
Over the last one year, Torrent Pharma has moved up from Rs 1,874.2 to Rs 3,414.5, registering a gain of Rs 1,540.3 (up 82.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,793.0, registering a gain of 55.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 201.2%), Glenmark Pharma (up 120.1%) and SUVEN PHARMACEUTICALS (up 119.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,344.7 (down 0.9%).
The top losers among the BSE Sensex today are Indusind Bank (down 19.2%) and M&M (down 4.6%). The most traded stocks in the BSE Sensex are Tata Steel and Indusind Bank.
In the meantime, NSE Nifty is at 24,101.5 (down 1.2%). Indusind Bank and M&M are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 79,344.7, registering a gain of 14,772.8 points (up 22.9%).
Torrent Pharma net profit grew 20.9% YoY to Rs 4,570 million for the quarter ended June 2024, compared to a profit of Rs 3,780 million a year ago. Net sales rose 10.3% to Rs 28,590 million during the period as against Rs 25,910 million in April-June 2023.
For the year ended March 2024, Torrent Pharma reported 33.0% increase in net profit to Rs 16,564 million compared to net profit of Rs 12,452 million during FY23. Revenue of the company grew 11.5% to Rs 107,278 million during FY24.
The current Price to earnings ratio of Torrent Pharma, based on rolling 12 month earnings, stands at 66.6.
Equitymaster requests your view! Post a comment on "Torrent Pharma Gains 3%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!